PRESS RELEASE Ushercell Enters International Phase II Trial for Bacterial Vaginosis Treatment and Prevention

ansell condom

com

The campaign,
"Make a Difference," aims to help to reduce the incidence of STDs and HIV/AIDS
by creating urgency among sexually active men and women to practice safer sex
and use condoms. Throughout this campaign, Trojan hopes to reach a broader
sexually active audience who might not consider their personal risk of STDs
and HIV/AIDS.
There are 26 varieties of Trojan brand condoms.

lubricating fairhaven

In a subsequently published report delivered at the 12th Conference on
Retroviruses and Opportunistic Infections in Boston, the results of a
clinical trial conducted by the HIV Prevention Trials Network (HPTN049)
wherein 59 HIV+ women enrolled to assess Changes in Vaginal Flora
Associated with Vaginal Microbicides, 43% of these participants had
Bacterial Vaginosis at the time of enrollment. Trojan brand latex condoms are made from premium quality
latex to help reduce the risk of unwanted pregnancy and sexually transmitted
diseases. Known for its breakthrough
creativity and immediate results, its clients include AFLAC, Coldwell Banker,
Continental Airlines , Foxwoods Resort Casino, Panasonic, Pfizer (Celebrex and
Zoloft), Procter + Gamble (Clairol Herbal Essences, Aussie, Infusium, Swiffer
and Dawn), Revlon, Trojan brand condoms and US Bank.

fairhaven predictors

Each condom is electronically tested to help ensure reliability.

lubricating vitalis

Jose Simoes, at
the University of Campinas, Sao Paulo, Brazil, and will involve 60 women
having a clinical diagnosis of BV, and no other sexually transmitted
diseases or reproductive tract infections. Advertising Aims To Reach Primetime TV Viewers With Safer Sex Messages;
Personalize Devastating Effects of Unprotected Sex

PRINCETON, N..

vitalis petoskey

Polydex Pharmaceuticals Limited (NASDAQ: POLXF) is
pleased to announce the commencement of a randomized, blinded Phase II
clinical trial of Cellulose Sulphate (Ushercell), a microbicidal gel which
is being tested for its effectiveness in the treatment of Bacterial
Vaginosis (BV), the most common vaginal disorder among reproductive-age
women, present in 15-25% of gynecologic patients and up to 60% of women
seen at sexually transmitted diseases clinics. By day 14 of that trial,
89% of the patients with BV that were assigned the use of Ushercell no
longer had BV. Jose Simoes and Dr. The ads will begin airing this week..

ehsan cervical

The study will be carried out under the direction of Dr..

fairhaven biofilm

."

The ads can be viewed by visiting http://www.trojancondoms.

redbank ovulation

Actual events or results may differ
materially from the Company's expectations, which are subject to a number
of known and unknown risks and uncertainties including but not limited to
changing market conditions , future actions by the U.

New Trojan(R) Condoms Campaign Aims to Make a Difference and Strike Down Complacency About Unprotected Sex

" This is a bold reminder for
the need to take personal action in protecting oneself when sexually active.

allendale vitalis

A BV treatment may represent our
fastest route to the market for Ushercell ," he continued. CONRAD, which was established and funded by
USAID at the Eastern Virginia Medical School, has focused on developing
safe, effective, acceptable and affordable methods of contraception and
microbicides for the prevention HIV/AIDS and other sexually transmitted
infections.

Please visit our website: www. "This
campaign does just that -- it presents the facts in a responsible and
meaningful way that can't be ignored.
"In creating this campaign for Trojan, we knew we had to break new ground,
be provocative and reach people at the right time," said Linda Kaplan Thaler ,
CEO and Chief Creative Officer of The Kaplan Thaler Group.

predictors conceptus

S., The sobering fact that millions of
people may be taking unnecessary health risks is the catalyst for a new
advertising campaign from the makers of Trojan(R) brand condoms.
Subsequent ads will focus on other potential risks as well as specific
consumer segments.
The Trojan(R) Sexual Health Monitor, an annual nationwide survey of men and
women 18 - 24 years old, found that 87 percent of women and 75 percent of
heterosexual men have had sex without a condom, and only 37 percent of women
say they always or often use a condom .

cervical lubricating

BV is defined as a clinical syndrome in which the normal
lactobacilli-predominant vaginal flora is replaced by an overgrowth of
Gardnerella vaginalis and anaerobic microorganisms. Lourens Zaneveld to assess its potential as a
treatment for BV," said George Usher, President and CEO of Polydex. All participants will be
counseled to use an effective non-barrier method of contraception
throughout the trial.
"Consistent with our leadership position, we feel there is an urgent need
to articulate these important sexual health messages in a way that
personalizes the risks and, hopefully, forms the basis for changing behavior
so that consumers who are sexually active use condoms consistently," said Jim
Daniels, Vice President of Marketing for Trojan(R) brand condoms . The campaign is comprised of various executions, all with a
poignant and sobering message in striking white type on a black background. "As the market leader, one of our priorities
is to help decrease the incidence of STDs and unwanted pregnancies. It's our
mission to make sure people understand potential risks and protect themselves
with responsible and consistent use of condoms, if they do not choose to be
abstinent.

allendale condom

BV is also associated with
increased risk of HIV acquisition and transmission .

About The Kaplan Thaler Group
The Kaplan Thaler Group (http://www.

veos hardcover

"The
second study with equally encouraging indications of BV clearance confirms
the potential we envision for Ushercell. A report could be available as early as late 2006.

CONRAD, located in Arlington, VA , has played an instrumental role in
developing cellulose sulphate with the support of USAID and private
foundations, and in clinical collaboration with Family Health
International, WHO and NIH. While condom ads have run on network
TV in the past, they have been relegated to late night viewing times .kaplanthaler.

ovulation condoms

Food and Drug
Administration or equivalent foreign regulatory authorities as well as
results of pending or future clinical trials.polydex.
The first ad states that "40 percent of people who are HIV positive don't
tell their partners.S.

condom knutsford

It is estimated that this randomized , blinded Phase II clinical study will
last approximately six months, after which the data will be unblinded and
analyzed."
While sexually active adults claim they understand the risks of
unprotected sex, this understanding isn't always reflected in their behavior.com.

knutsford conceptus

Not only is BV a common problem that requires treatment,
Bacterial Vaginosis may also act as a co-factor in the heterosexual
transmission of HIV. We are extremely proud of this campaign
and with the decision to pursue airing these commercials on network television
during primetime.com) has been ranked as
the fastest growing advertising agency in the U.

darul vitalis

In an earlier published
study, Ushercell demonstrated a growth-inhibition effect on BV-associated
bacteria in vitro, and the study report concluded with recommendations to
further study the effects of Ushercell as a treatment for BV.





Polydex Website


"We are delighted that Ushercell continues to show a high safety profile
and broad spectrum antimicrobial activity, securing recommendations from
Dr.

CONRAD and Family Health International are conducting the Phase III HIV
Prevention trials in Africa and India, with funding from USAID and the Bill
and Melinda Gates Foundation. other than abstinence, the only way to
protect yourself is to use a condom every time.

prophylactics redbank

The protocol
for this study has been designed to conform to FDA guidelines. A Phase II clinical trial for fertility regulation
has recently been completed in the United States and two Phase III trials
to determine efficacy in the prevention of HIV/AIDS, gonorrhea, chlamydia
and herpes 1 and 2 are ongoing in Africa and India.

Polydex Pharmaceuticals Limited, based in Toronto, Ontario, Canada, is
engaged in the research, development, manufacture and marketing of
biotechnology-based products for the human pharmaceutical market, and also
manufactures bulk pharmaceutical intermediates for the worldwide veterinary
pharmaceutical industry.

Note: This press release may contain forward-looking statements, within the
meaning of the United States Securities Act of 1933, as amended, and the
United States Securities Exchange Act of 1934, as amended, regarding
Polydex Pharmaceuticals Limited. More Americans trust the
Trojan brand than any other condom.

ansell cervical

J.

Some sites may contain graphic images, but no offensive or Adult sites or material will be found here.

conceptus biofilm

Therefore, the impact of Ushercell as a BV treatment
warrants further study. The two HIV prevention trials are expected to
last approximately three years, with a further year required to evaluate
the data. The tone of the advertising is
informational, providing facts and figures in a responsible manner that
effectively raises the viewers' consciousness and awareness about the
potential consequences of unprotected sex among those who are sexually active.

conceptus minimally

Other risk factors discussed
in the Company's filings with the United States Securities and Exchange
Commission may also affect the actual results achieved by the Company. By
airing during primetime hours as well , the message of the ads will reach a
much broader audience than in late night alone. "We believe the
combination of a breakthrough, message-driven campaign with first-ever
primetime exposure will make a huge difference. We believe it is essential to take these
advertisements to a broader audience if we are to make a meaningful
difference," continued Daniels.

ehsan condoms

Polydex has committed the necessary funding to complete this trial, and
CONRAD continues its support in the development of Ushercell by providing
the clinical trial supplies necessary to carry out this trial.

fairhaven predictors

Includes companies whose products concern human sexuality, fertility testing, pregnancy, and birth control.

prophylactics biofilm

Ushercell is a high molecular weight cellulose sulphate polymer derived
from natural cotton, and has successfully completed numerous Phase I safety
and tolerability trials.
The campaign also marks a first, in that some broadcast networks have
agreed to air the spots during primetime."
The "Make a Difference" campaign, created by award-winning advertising
agency The Kaplan Thaler Group, signals a distinct departure from the brand's
past efforts." and ".
"We hope these ads will spark a much needed national dialogue about
responsible sexual behavior.

About Trojan
Trojan brand condoms are America's #1 condom and have been trusted for
nearly 90 years .

ansell lubricant

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)